Friday, 2 September 2011

MS Trust expresses concerns about NICE guidance on fingolimod


Source MS Trust:
NICE (National Institute of Health and Clinical Excellence) issued its draft guidance on 5 August 2011. The guidance stated that fingolimod is not recommended for the treatment of relapsing remitting multiple sclerosis.  Read more here.